| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/25/2002 | EP1243272A2 Crystalline amifostine compositions and methods for the preparation and use of same |
| 09/25/2002 | EP1243271A1 Nasal drops containing fused pyridazine derivatives |
| 09/25/2002 | EP1243264A2 Inhibition of nitric oxide production by retinoic acid |
| 09/25/2002 | EP1243256A1 Vaccines absorbable by the transmucosal way |
| 09/25/2002 | EP1242624A2 Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements |
| 09/25/2002 | EP1242609A2 Novel colloid synthetic vectors for gene therapy |
| 09/25/2002 | EP1242608A2 Method of achieving persistent transgene expression |
| 09/25/2002 | EP1242590A2 Human lyases and associated proteins |
| 09/25/2002 | EP1242585A1 IDENTIFICATION OF NOVEL SPLICE VARIANTS OF THE HUMAN CATALYTIC SUBUNIT C BETA OF cAMP-DEPENDENT PROTEIN KINASE AND THE USE THEREOF |
| 09/25/2002 | EP1242584A2 Human kinases |
| 09/25/2002 | EP1242583A2 Human oxidoreductase proteins |
| 09/25/2002 | EP1242452A2 Chimeric natriuretic peptides |
| 09/25/2002 | EP1242451A2 Compositions and methods for inhibiting endothelial cell proliferation |
| 09/25/2002 | EP1242447A1 Compounds and use thereof to modify transport across cell membranes |
| 09/25/2002 | EP1242438A1 Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use |
| 09/25/2002 | EP1242437A2 Novel stromelysin inhibitors |
| 09/25/2002 | EP1242432A1 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b) |
| 09/25/2002 | EP1242431A1 Aromatic phosphonates as protein tyrosine phosphatase 1b (ptp-1b) inhibitors |
| 09/25/2002 | EP1242426A1 Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides as hiv protease inhibitors |
| 09/25/2002 | EP1242421A1 4-[aryl(8-azabicyclo[3.2.1] octan-3-yl)] aminobenzoic acid derivatives |
| 09/25/2002 | EP1242415A1 3-thiazol-4-yl-pyrrolidine derivatives as amp-specific phosphodiesterase inhibitors |
| 09/25/2002 | EP1242413A1 Substituted 1,3,4-oxadiazoles and a method of reducing tnf-alpha levels |
| 09/25/2002 | EP1242410A1 Novel compounds |
| 09/25/2002 | EP1242409A2 Substituted bisindolylmaleimides |
| 09/25/2002 | EP1242408A1 Substituted bisindolylmaleimides for the inhibition of cell proliferation |
| 09/25/2002 | EP1242407A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 09/25/2002 | EP1242403A1 2,4-diaminopyrimidine compounds usful as immunosuppressants |
| 09/25/2002 | EP1242402A2 Novel compounds |
| 09/25/2002 | EP1242401A1 Cytotoxic agents comprising taxanes and their therapeutic use |
| 09/25/2002 | EP1242400A1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 09/25/2002 | EP1242399A1 $g(a)-ARYLETHYLPIPERAZINE DERIVATIVES AS NEUROKININ ANTAGONISTS |
| 09/25/2002 | EP1242397A1 Trans olefinic glucokinase activators |
| 09/25/2002 | EP1242389A2 Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them |
| 09/25/2002 | EP1242385A1 Cytokine, especially tnf-alpha, inhibitors |
| 09/25/2002 | EP1242382A1 Tricyclic protein kinase inhibitors |
| 09/25/2002 | EP1242379A1 Curcumin analogues for treating cancer |
| 09/25/2002 | EP1242372A1 Inhibitors of farnesyl protein transferase |
| 09/25/2002 | EP1242371A1 Hydrazone and oxime derivatives of pyrrolidine as amp-specific phosphodiesterase inhibitors |
| 09/25/2002 | EP1242367A1 2-[3-amino-4-(n-hydroxyamino)-succinylamino-acetamides for use as cd23 formation inhibitors |
| 09/25/2002 | EP1242365A1 Acyl pseudodipeptides which carry a functionalised auxiliary arm |
| 09/25/2002 | EP1242364A1 Adamantane derivatives |
| 09/25/2002 | EP1242120A2 Combinations of growth factors and i:upa or i:mmp for the treatment of damaged tissue |
| 09/25/2002 | EP1242114A2 Use of enzymes for skin expansion |
| 09/25/2002 | EP1242108A1 Optimized minigenes and peptides encoded thereby |
| 09/25/2002 | EP1242105A2 Combination of ginseng and ginkgo to improve cognitive skills |
| 09/25/2002 | EP1242104A2 Process of obtaining thylakoids from plants, pure thylakoids and use thereof |
| 09/25/2002 | EP1242103A1 Extracts derived from pueraria mirifica, butea superba and/or mucuna collettii and extraction thereof |
| 09/25/2002 | EP1242098A2 Aqueous ionic solutions and their uses in particular in ophthalmology |
| 09/25/2002 | EP1242094A1 Methods for treating mild cognitive impairment |
| 09/25/2002 | EP1242088A1 Oral mucosal dosage forms of apomorphine |
| 09/25/2002 | EP1242085A1 Benzimidazole compounds having nociceptin receptor affinity |
| 09/25/2002 | EP1242082A1 Methods and compositions for the prevention and treatment of atherosclerosis, restenosis and related disorders |
| 09/25/2002 | EP1242081A1 Caspases and apoptosis |
| 09/25/2002 | EP1242076A1 2-benzyl and 2-heteroaryl benzimidazole nmda/nr2b antagonists |
| 09/25/2002 | EP1242075A2 Indole compounds |
| 09/25/2002 | EP1242069A2 Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies |
| 09/25/2002 | EP1242068A1 Endogenous nitric oxide synthesis under conditions of low oxygen tension |
| 09/25/2002 | EP1242063A1 Compositions and methods for treatment of neurological disorders and neurodegenerative diseases |
| 09/25/2002 | EP1242058A1 Use of cyp2d6 inhibitors in combination therapies |
| 09/25/2002 | EP1242050A2 Survivin promotion of angiogenesis |
| 09/25/2002 | EP1175432A4 Processes for the synthesis of oligomers using phosphoramidite compositions |
| 09/25/2002 | EP1146897B1 Use of a melanoma inhibiting activity factor (mia) for cartilage and bone repair |
| 09/25/2002 | EP1073651B1 Indolyl derivatives as serotonergic agents |
| 09/25/2002 | EP1070059B1 Chromanone and thiochromanone derivatives |
| 09/25/2002 | EP1003528B1 Method of enhancing bioavailability of fexofenadine and its derivatives |
| 09/25/2002 | EP0994710B1 Pharmaceutical compositions for oral administration, comprising a benzhydrylpiperazine and a cyclodextrin |
| 09/25/2002 | EP0986390B1 Pharmaceutical compositions containing cinchonine dichlorhydrate |
| 09/25/2002 | EP0977559B1 Enhanced anti-cancer agent delivery to solid tumors by primer compounds |
| 09/25/2002 | EP0948345B1 Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction |
| 09/25/2002 | EP0942745B1 Use of hyaluronidase |
| 09/25/2002 | EP0931081B1 Pyridazino 4,5-b]-quinoline 5-oxide derivatives, their preparation and their use as glycine antagonists |
| 09/25/2002 | EP0925299B1 Pyrazolopyridine compound and pharmaceutical use thereof |
| 09/25/2002 | EP0923550B1 Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists |
| 09/25/2002 | EP0912534B1 Muscarinic antagonists |
| 09/25/2002 | EP0912184B1 Use of k-252a derivative for the treatment of peripheral or central nerve disorders, and cytokine overproduction |
| 09/25/2002 | EP0910398B1 Method of stimulating cilia |
| 09/25/2002 | EP0835258B1 Novel camptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues |
| 09/25/2002 | EP0817782B1 Phenyl derivatives useful as endothelin receptor antagonists |
| 09/25/2002 | EP0804591B1 Serum paraoxonase |
| 09/25/2002 | EP0751948B1 Novel phosphoramidate and phophorothioamidate oligomeric compounds |
| 09/25/2002 | EP0746556B1 Tricyclic compounds having affinity for the 5-ht1a receptor |
| 09/25/2002 | EP0746312B1 Guanylhydrazones for treating inflammatory conditions |
| 09/25/2002 | EP0702551B1 Compositions and methods for reparation and prevention of fibrotic lesions |
| 09/25/2002 | CN1371388A Hexapeptide with stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation differentiation and apoptosis |
| 09/25/2002 | CN1371385A Immunopotentiating compositions |
| 09/25/2002 | CN1371376A Substituted purin derivatives as inhibitors of cell adhesion |
| 09/25/2002 | CN1371374A Substituted heterocycle fused gamma-carbolines |
| 09/25/2002 | CN1371371A Novel derivatives of flavones, xanthones and coumarins |
| 09/25/2002 | CN1371369A Substituted 3-phenyl-5-alkoxl-1,3,4-oxidazol-2-ones and their use das lipase inhibitors |
| 09/25/2002 | CN1371366A Benzamide formulation with histone deacetylase inhibitor activity |
| 09/25/2002 | CN1371365A Piperidine alcohols |
| 09/25/2002 | CN1371359A Aminobenzophenones as inhibitors IL-1 beta and TNF-alpha |
| 09/25/2002 | CN1371357A Aminobenzoic acid derivatives |
| 09/25/2002 | CN1371291A Method and formula for tumor remission and suppression of cancer |
| 09/25/2002 | CN1371286A Use of cyclooxygenase-2 inhibitor matrix metallappoteinase inhibitor antineoplastic agent and optionally radiation as combination treatment of neoplasia |
| 09/25/2002 | CN1371280A Treatment of migraine by the administration of alpha-lipoic acid or derivatives thereof |
| 09/25/2002 | CN1370591A Foot health keeping medicine |
| 09/25/2002 | CN1370567A Antifatigue Chinese medicine health article |
| 09/25/2002 | CN1370560A Intelligence growth promoting antilipenic nutritous health care soft capsule and its prepn |
| 09/25/2002 | CN1370559A Anti-senility antilipemic nutritious health care soft capsule and its prepn |